These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11236070)

  • 1. Dose-dependent olanzapine-associated leukopenia: three case reports.
    Kodesh A; Finkel B; Lerner AG; Kretzmer G; Sigal M
    Int Clin Psychopharmacol; 2001 Mar; 16(2):117-9. PubMed ID: 11236070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
    Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A
    Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of leukopenia in treatment with risperidone in an adolescent].
    Etain B; Roubaud L; Le Heuzey MF; Mouren Simeoni MC
    Encephale; 2000; 26(5):81-4. PubMed ID: 11192809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia.
    Jackson RS
    Arch Gen Psychiatry; 2001 Jul; 58(7):706-7. PubMed ID: 11448379
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
    Dernovsek MZ; Tavcar R
    Int Clin Psychopharmacol; 2000 Jul; 15(4):237-8. PubMed ID: 10954065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine versus other antipsychotics in the treatment of schizophrenia.
    Masand PS
    J Clin Psychiatry; 2001 Oct; 62(10):828-9. PubMed ID: 11816875
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
    Teter CJ; Early JJ; Frachtling RJ
    J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine-induced and Risperidone-induced Leukopenia: A Case of Synergistic Adverse Reaction?
    Woon LS; Tee CK; Gan LLY; Deang KT; Chan LF
    J Psychiatr Pract; 2018 Mar; 24(2):121-124. PubMed ID: 29509183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X; Wang X
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
    Aubry JM; Simon AE; Bertschy G
    J Clin Psychiatry; 2000 Sep; 61(9):649-55. PubMed ID: 11030485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
    Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
    J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
    Lindenmayer JP; Volavka J; Lieberman J; Sheitman B; Citrome L; Chakos M; Czobor P; Parker B; Iskander A
    J Clin Psychopharmacol; 2001 Aug; 21(4):448-53. PubMed ID: 11476131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
    Weiss EL; Longhurst JG; Bowers MB; Mazure CM
    J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.